TFFP - TFF Pharmaceuticals Inc. Market Cap to Sales Volume

Brandmark of TFF Pharma (TFFP)

The normalized P/S of TFF Pharmaceuticals (TFFP) on the GURU.Markets time-series chart, where the value 22.30 corresponds to the current metric, is based on the potential for licensing royalties from pharma behemoths. The business relies on innovations in the creation of dry powders for inhalation, establishing a technological barrier. However, geopolitical conflicts and sanctions restrict access to components and narrow global sales markets.

TFF Pharmaceuticals, Inc (TFFP) - P/S Multiple from 07/04/2022 to 09/24/2023

Metric breakdowns and analytics for TFF Pharma (TFFP)

- share price and consensus valuation forecast:
Price Performance Chart tffpharma.com|TFFP - Consensus Target
- market capitalization statistics:
Market Value TFF Pharma|TFFP - Enterprise Value
- book capitalization information:
Share Book Value TFF Pharmaceuticals|TFFP - Book Capitalization|Market Capitalization to Net Assets tffpharma.com|TFFP - Cumulative Company Assets
- debt obligations and liquidity statistics:
All Debt to Shareholders' Equity Ratio TFF Pharmaceuticals|TFFP - Long-Term Debt to Equity|Current Liabilities to Equity TFF Pharmaceuticals, Inc|TFFP - Company Aggregate Debts|Debt to Net Assets Ratio TFF Pharma|TFFP - Company Long-Term Debts|Company Short-Term Debts TFF Pharmaceuticals|Intermediate Coverage Ratio tffpharma.com
- earnings and valuation multiples indicators:
TFFP - Company Net Income|Future Profit TFF Pharmaceuticals|TFFP - P/E Multiple|Forward P/E Multiple TFF Pharmaceuticals Inc.|TFFP - PEG Multiple|Enterprise Value to EBITDA Ratio TFF Pharma|TFFP - Operating profit EBITDA|Net earnings per one share for the last twelve months TFF Pharmaceuticals|TFFP - Net earnings per share for the last 12 months|Quarterly EPS earnings growth tffpharma.com|TFFP - Net earnings per share growth this year|Projected earnings per share increase next year TFF Pharmaceuticals
- issuer revenue and sales details:
TFFP - Revenue and Sales Volume|Company Future Sales tffpharma.com|TFFP - P/S Multiple|Forward Price-to-Revenue Multiple TFF Pharma
General company analysis:tffpharma.com, TFFP
Finished products of TFF Pharmaceuticals Inc.

The P/S ratio determines the market value of a business relative to its annual sales volume, measuring the premium investors are willing to pay per unit of revenue. Analyzing the P/S ratio dynamics of TFF Pharmaceuticals (TFFP) reveals how the loss of fundamental value due to asset liquidation and the cessation of operations transforms the metric into an indicator of pure speculative decay.

Competing companies

HLN (haleon.com) - Market Capitalization-to-Revenue Ratio|Kenvue - Market Cap to Revenue|Market Cap to Sales Volume VRNA (Verona Pharma PLC)|Jyong Biotech Corp - P/S Multiple|Price-to-Sales Ratio LGND|AMRX: P/S Multiple|Price-to-Sales Ratio PRGO (perrigo.com)|Market Cap to Revenue ALVO|LQDA: Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio Galapagos Genomics (GLPG)|ANIP: Price-to-Sales Ratio|P/S Multiple MNKD (MannKind Corporation)|Market Capitalization-to-Revenue Ratio AMPH|Pacira BioSciences, Inc. - P/S Multiple|SPRY - P/S Multiple|Theravance (TBPH) - Price-to-Revenue Ratio|Aquestive Corp - Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio scPharmaceuticals, Inc.|Market Cap to Revenue Tectonic (TECX)|P/S Multiple TNXP|P/S Multiple sxtchina.com (SXTC)|P/S Multiple EPRX (Eupraxia Pharmaceuticals Inc.)|BHST - Market Cap to Revenue|eXoZymes Inc - P/S Multiple|Price to Sales Oramed Pharmaceuticals|ENTX (enterabio.com) - Market Cap to Revenue|MindWalk Holdings, Inc. (HYFT) - P/S Multiple|Market Cap to Revenue ABVC|CPIX (Cumberland Corp) - Market Cap to Sales Volume|P/S Multiple QNTM|Price-to-Revenue Coefficient fibrogen.com|P/S Multiple TELO (Telomir Pharmaceuticals, Inc.)|RANI - Market Cap to Revenue|Synergy CHC Corporation - P/S Multiple|RLYB - P/S Multiple|lexariabioscience.com (LEXX) - Price-to-Revenue Ratio|PULM (pulmatrix.com) - Price-to-Revenue Ratio|Price-to-Revenue Ratio Pheton Holdings Limited|Aptorum (APM) - Price-to-Revenue Coefficient|Market Cap to Revenue LYRA (Lyra Therapeutics, Inc)|Market Cap to Sales Volume IBO|P/S Multiple TNFA (TNF Pharmaceuticals, Inc.)|YCBD (cbdMD Inc.) - Price-to-Sales Ratio|PainReform - P/S Multiple|Price-to-Sales Ratio CYTO|Lipella (LIPO) - Price-to-Revenue Ratio|Price-to-Sales Ratio OPTN (OptiNose Corp)|Price-to-Revenue Ratio Pieris Pharmaceuticals|procapsgroup.com - Price-to-Sales Ratio|P/S Multiple PTPI|QLI (Qilian International Holding Group) - Market Capitalization-to-Revenue Ratio|P/S Multiple SLRN (ACELYRIN, Inc.)